Cargando…
Potential therapeutic targets for atherosclerosis in sphingolipid metabolism
Sphingolipids, such as sphingomyelins, ceramides, glycosphingolipids, and sphingosine-1-phosphates (S1P) are a large group of structurally and functionally diverse molecules. Some specific species are found associated with atherogenesis and provide novel therapeutic targets. Herein, we briefly revie...
Autores principales: | Yu, Zemou, Peng, Qing, Huang, Yining |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6422862/ https://www.ncbi.nlm.nih.gov/pubmed/30890654 http://dx.doi.org/10.1042/CS20180911 |
Ejemplares similares
-
Plasma lipidomic analysis of sphingolipids in patients with large artery atherosclerosis cerebrovascular disease and cerebral small vessel disease
por: You, Qian, et al.
Publicado: (2020) -
Sphingolipid Metabolism and Signaling in Lung Cancer: A Potential Therapeutic Target
por: Lin, Mengmeng, et al.
Publicado: (2022) -
Regulation of Sphingolipid Metabolism by MicroRNAs: A Potential Approach to Alleviate Atherosclerosis
por: Jahangir, Zainab, et al.
Publicado: (2018) -
Sphingolipid and Ceramide Homeostasis: Potential Therapeutic Targets
por: Young, Simon A., et al.
Publicado: (2012) -
Targeting Sphingolipid Metabolism as a Therapeutic Strategy in Cancer Treatment
por: Janneh, Alhaji H., et al.
Publicado: (2022)